The product is produced under strict Good Manufacturing Practices (GMP) and Indian Pharmacopoeia (IP) standards, with complete documentation and quality testing for parameters such as ash content, hardness, pH suitability, and absence of contaminants.

One of the key strengths of TOXIGON lies in its clinically optimized pore architecture. The activation process is precisely designed to generate a predominantly microporous structure with a pore diameter of less than 2 nm. This micropore-rich structure—contributing nearly 75% to 95% of the total pore surface—provides an exceptionally large surface area of about 1500 to 2000 m² per gram. Such massive surface exposure dramatically enhances its capacity to trap and hold toxic molecules. With a micropore volume in the range of 0.40 to 0.80 m³/g and an adsorption capacity exceeding 1200 mg/g, TOXIGON effectively binds a wide variety of poisons such as pharmaceuticals, alkaloids, pesticides, organic compounds, and metabolic by products. These physicochemical characteristics make it highly effective during the crucial early minutes of poisoning management, when rapid adsorption can significantly reduce systemic absorption. The charcoal is further refined and pH-adjusted to ensure safe ingestion and rapid dispersion in aqueous suspensions, promoting reliable gastric residence and quick clinical action. Its high mechanical hardness prevents unwanted powdering, ensures stable suspension, and maintains its adsorption efficiency throughout administration. Every batch is extensively evaluated under pharmacopeial specifications for purity, particle uniformity, hardness, heavy-metal absence, and overall adsorption performance.